Dr. Jeffrey Freitag named chief medical officer of PharmaNet

Tuesday, March 8, 2011 10:57 AM

PharmaNet Development Group, a provider of pharmaceutical services to biotechnology, generic drug and medical device companies, has promoted Jeffrey Freitag, M.D., senior vice president of PharmaNet Consulting, to chief medical officer.

Dr. Freitag will be the senior medical representative and guide physicians involved in phase I through phase III clinical trials. He will retain his current responsibilities heading the team of regulatory and pharmaceutical consultants.

Dr. Freitag has worked in the pharmaceutical industry for more than 25 years, including positions as vice president of clinical drug development at The Liposome Company and vice president of R&D at Bone Care International.  He is board certified in Internal Medicine and Nephrology.

 

Share:          
CWWeekly

April 13

Quintiles-Quest Diagnostics joint venture latest in CRO-central lab deals, more could be on horizon

Biotech companies raise record amount of capital in Q1

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs